Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$278.5 - $352.75 $32,027 - $40,566
-115 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $26,415 - $34,544
-90 Reduced 43.9%
115 $228,000
Q2 2018

Aug 09, 2018

SELL
$257.52 - $306.91 $32,189 - $38,363
-125 Reduced 37.88%
205 $59,000
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $11,705 - $16,555
-45 Reduced 12.0%
330 $90,000
Q4 2017

Feb 12, 2018

BUY
$307.64 - $344.58 $115,365 - $129,217
375
375 $119,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.